Physical activity improves work ability
A study conducted at the University of Jyväskylä shows that regular leisure-time physical activity started at a young age prevents a decrease in work ability at the end… read more.
A study conducted at the University of Jyväskylä shows that regular leisure-time physical activity started at a young age prevents a decrease in work ability at the end… read more.
People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and… read more.
PROCEPT BioRobotics highlighted the latest update to the European Association of Urology (EAU) Guidelines for male lower urinary tract symptoms (LUTS), which include an upgrade of Aquablation therapy… read more.
There appears to be no association between hormonal contraception and the prevalence of idiopathic intracranial hypertension, researchers reported on March 25, 2026 in Neurology, the medical journal of… read more.
Researchers report that the antidepressant fluvoxamine has significantly reduced long COVID–related fatigue, and that the diabetes drug metformin has no such benefit. “Patients taking fluvoxamine reported steadily improving… read more.
The FDA approved Boehringer Ingelheim’s Hernexeos (zongertinib tablets) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) whose tumors have HER2 (ERBB2) tyrosine kinase… read more.
A new analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health finds that out-of-pockets caps on insulin for Medicare Part D beneficiaries have reined… read more.
Abbott announced results from the FreeDM2 randomized controlled trial (RCT) showing that people using FreeStyle Libre continuous glucose monitoring (CGM) technology had better glucose outcomes than those using… read more.
Nearly 1 in 2 Americans has high blood pressure—sometimes called the “silent killer” because it harms the heart and blood vessels—but many people don’t know they have it…. read more.
Hansa Biopharma AB announced that the FDA has notified the company that the previously accepted Biologics License Application (BLA) for imlifidase has been assigned a Prescription Drug User… read more.
NICE(UK): Molnupiravir is recommended as an option for treating mild to moderate COVID‑19 in adults who have a positive SARS‑CoV‑2 test, only if: i) they have 1 or… read more.
Emergency Medicine & Intensive Care
The latest, most comprehensive data on the scale of drink spiking in the UK will be presented to the public for the first time at Anglia Ruskin University… read more.